COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04609423


Column Value
Trial registration number NCT04609423
Full text link
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov

Arne Vasli Lund Søraas

Contact
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov

Not reported

Registration date
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-10-30

Recruitment status
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Prevention

Inclusion criteria
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

inclusion criteria: - any person >18 years with a norwegian personal identity number

Exclusion criteria
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

- history of renal failure or dialysis, hypercalcemia, severe liver disease (cirrhosis), sarcoidosis or other granulomatous diseases (wegener) - allergy to fish or corn oil. - pregnancy or planned pregnancy before summer 2021 - vegan diet - age >75 years old at inclusion based on the norwegian personal identity number - difficulty in swallowing cod liver oil or other oils - previous covid-19 disease - for caucasians only: use of any supplement containing more than trace amounts of vitamin d or omega-3 fatty acids at inclusion (vitamin d levels in non-caucasians living in norway are frequently low even among those self-reporting using dietary supplements). this criterion will be relaxed if too few participants volunteer for the study and only caucasians that use cod liver oil or an equivalent dietary supplement (with omega 3 and vitamin d) more than 5-7 times per week will be excluded.

Number of arms
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Oslo University Hospital

Inclusion age min
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

75

Countries
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Norway

Type of patients
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Healthy volunteers

Severity scale
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

N/A

Total sample size
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov

47210

primary outcome
Last imported at : April 7, 2022, 9:30 p.m.
Source : ClinicalTrials.gov

Number of participants diagnosed with New Covid-19;Number of participants diagnosed with serious Covid-19;Number of participants with negative SARS-CoV-2 test;Number of participants with self-reported airway infection

Notes
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov

Phase 4

Arms
Last imported at : Oct. 31, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 307, "treatment_name": "Cod liver oil", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]